These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 7164137)

  • 1. Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué.
    Ivanoff B; Duquesnoy P; Languillat G; Saluzzo JF; Georges A; Gonzalez JP; McCormick J
    Trans R Soc Trop Med Hyg; 1982; 76(6):719-20. PubMed ID: 7164137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against haemorrhagic fever viruses in Kenya populations.
    Johnson BK; Ocheng D; Gichogo A; Okiro M; Libondo D; Tukei PM; Ho M; Mugambi M; Timms GL; French M
    Trans R Soc Trop Med Hyg; 1983; 77(5):731-3. PubMed ID: 6419422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral haemorrhagic fevers caused by Lassa, Ebola and Marburg viruses.
    Curtis N
    Adv Exp Med Biol; 2006; 582():35-44. PubMed ID: 16802617
    [No Abstract]   [Full Text] [Related]  

  • 4. The nasty viruses--Lassa, Marburg, and Ebola.
    Simpson DI
    Br J Hosp Med; 1980 Feb; 23(2):191, 193-4. PubMed ID: 6768412
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa.
    Jeffs B
    Trop Doct; 2006 Jan; 36(1):1-4. PubMed ID: 16483416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Viral hemorrhagic fever--Ebola hemorrhagic fever, Marburg disease and Lassa fever].
    Hotta H
    Rinsho Byori; 1998 Jul; 46(7):651-5. PubMed ID: 9721531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral haemorrhagic fever surveillance in Kenya, 1980-1981.
    Johnson BK; Ocheng D; Gitau LG; Gichogo A; Tukei PM; Ngindu A; Langatt A; Smith DH; Johnson KM; Kiley MP; Swanepoel R; Isaacson M
    Trop Geogr Med; 1983 Mar; 35(1):43-7. PubMed ID: 6684336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys.
    Johnson KM; Elliott LH; Heymann DL
    J Clin Microbiol; 1981 Nov; 14(5):527-9. PubMed ID: 7031084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Marburg, Ebole and Lassa virus infections].
    Denis F; Robin Y
    Dakar Med; 1979; 24(1):51-5. PubMed ID: 574072
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies to haemorrhagic fever viruses in Madagascar populations.
    Mathiot CC; Fontenille D; Georges AJ; Coulanges P
    Trans R Soc Trop Med Hyg; 1989; 83(3):407-9. PubMed ID: 2515626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Method for the simultaneous detection of immunofluorescing antibodies to the causative agents of different hemorrhagic fevers].
    Lukashevich IS; van der Groen G
    Vopr Virusol; 1985; 30(5):624-6. PubMed ID: 3907144
    [No Abstract]   [Full Text] [Related]  

  • 12. Marburg, Ebola and Rift Valley Fever virus antibodies in East African primates.
    Johnson BK; Gitau LG; Gichogo A; Tukei PM; Else JG; Suleman MA; Kimani R; Sayer PD
    Trans R Soc Trop Med Hyg; 1982; 76(3):307-10. PubMed ID: 6810518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse.
    Flaxman A; Sebastian S; Appelberg S; Cha KM; Ulaszewska M; Purushotham J; Gilbride C; Sharpe H; Spencer AJ; Bibi S; Wright D; Schmidt I; Dowall S; Easterbrook L; Findlay-Wilson S; Gilbert S; Mirazimi A; Lambe T
    PLoS Pathog; 2024 Jun; 20(6):e1012262. PubMed ID: 38924060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-epidemiologic and laboratory research on hemorrhagic fevers in Guinea].
    Boiro I; Lomonossov NN; Sotsinski VA; Constantinov OK; Tkachenko EA; Inapogui AP; Balde C
    Bull Soc Pathol Exot Filiales; 1987; 80(4):607-12. PubMed ID: 3440310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viral hemorrhagic fever].
    Kager PA
    Ned Tijdschr Geneeskd; 1998 Feb; 142(9):448-51. PubMed ID: 9562757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemorrhagic (Marburg, Ebola, Lassa, and Bolivian) fevers: epidemiology, clinical pictures, and treatment].
    Borisevich IV; Markin VA; Firsova IV; Evseev AA; Khamitov RA; Maksimov VA
    Vopr Virusol; 2006; 51(5):8-16. PubMed ID: 17087059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral hemorrhagic fever antibodies in Nigerian populations.
    Tomori O; Fabiyi A; Sorungbe A; Smith A; McCormick JB
    Am J Trop Med Hyg; 1988 Mar; 38(2):407-10. PubMed ID: 3128130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microbiological surveillance: viral hemorrhagic fever in Central African Republic: current serological data in man].
    Nakounné E; Selekon B; Morvan J
    Bull Soc Pathol Exot; 2000 Jan; 93(5):340-7. PubMed ID: 11775321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa.
    Van der Waals FW; Pomeroy KL; Goudsmit J; Asher DM; Gajdusek DC
    Trop Geogr Med; 1986 Sep; 38(3):209-14. PubMed ID: 3092415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research with the Marburg, Lassa and Ebola viruses].
    Pshenichnov VA; Makhlaĭ AA; Mikhaĭlov VV
    Vopr Virusol; 1993; 38(2):54-8. PubMed ID: 8059520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.